You are here

Septerna

Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs

Fierce Biotech

Wed, 05/14/25 - 10:56 am

‘A really rational IPO environment’: What does it takes for a biotech to go public now?

Fierce Biotech

Fri, 01/24/25 - 11:44 am

Rapport Therapeutics

Nasdaq debutante Septerna swells its IPO to $331m

Pharmaphorum

Thu, 10/31/24 - 09:16 am

GPCR drugmaker Septerna amasses $288M in IPO

BioPharma Dive

Fri, 10/25/24 - 10:59 am

Septerna plans $158M IPO to fund clinical readouts for GPCR pipeline

Fierce Biotech

Mon, 10/21/24 - 09:42 am

Septerna files for IPO on strength of preclinical data, vision for expanding GPCR landscape

Fierce Biotech

Thu, 10/3/24 - 10:32 am

hypoparathyroidism

Vertex gets in on GPCR game, paying Septerna $47M for undisclosed program

Fierce Biotech

Tue, 09/12/23 - 10:42 am

Vertex Pharmaceuticals

Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines

BioSpace

Wed, 07/12/23 - 11:15 pm